𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis

✍ Scribed by M. Farr; L. Waterhouse; A. E. Johnson; G. D. Kitas; R. W. Jubb; P. A. Bacon

Publisher
Springer
Year
1995
Tongue
English
Weight
525 KB
Volume
14
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sulfasalazine in early rheumatoid arthri
Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study
✍ Pekka Hannonen; Timo MΓΆttΓΆnen; Mikko Hakola; Martti Oka πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 991 KB

Objective. To investigate the efficacy and tolerability of sulfasalazine (SSZ) in the treatment of early rheumatoid arthritis (RA). Methods. Eighty patients (symptomatic disease <12 months) were randomly assigned to treatment with SSZ or placebo for 48 weeks. Clinical, laboratory, and scintigraphic

A double-blind, placebo-controlled study
A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis
✍ Nancy J. Olsen; Raye H. Brooks; John J. Cush; Peter E. Lipsky; E. William St. Cl πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 654 KB

Objective. To evaluate the efficacy of an antLCD5 ricin-linked immunoconjugate (CD5-IC) in patients with rheumatoid arthritis (RA). Methods. A total of 104 evaluable patients were enrolled in a multicenter, double-blind, multiple-dose, placebo-controlled study of CDS-IC. Results. Treatment with CD